Company intelligence / Profile preview

Reacta Healthcare

Deeside, Wales, United Kingdom

Ownership: Private
Development stage: Other

Overview

Reacta Healthcare develops, manufactures and commercializes pharmaceutical‑grade oral food challenge meals and diagnostic kits (e.g., peanut, egg, milk) used as the gold‑standard test in clinical trials and clinical practice to diagnose and monitor food allergies; products are commercial and used in clinical studies, but they are not therapeutics and therefore have no conventional clinical efficacy outcomes to summarize.

Therapeutic areas: Immunology
Modalities: Non-pharmacological therapyDevice
Industry: Consumable Medical Devices

Partnerships

Clinical trial sponsors and allergy centers using Reacta’s standardized oral food challenge meals (customers rather than formal disclosed strategic partnerships)

Beyond the preview

Go deeper on Reacta Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reacta Healthcare.

Explore the full profile